All In Biotech

Drug Trial Radar · NCT00151489

Safety and Efficacy Study of Pregabalin in Fibromyalgia

A Six-Month, Double-Blind, Placebo Controlled, Durability of Effect Study of Pregabalin for Pain Associated With Fibromyalgia

Last checked: Nov 20, 2026Latest source record: Jan 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,020 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,020

Actual

Start

Apr 2005

Primary completion

Not stated

Study completion Jun 2006

Sponsor

Sponsor type
Industry
First posted
Sep 9, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study of pregabalin and fibromyalgia is to see if 1. pregabalin reduces the pain of fibromyalgia and if this effect lasts for six months and 2. to see if different dosages work better (reduce pain and mild to no side effects) for different people.

Conditions

  • Fibromyalgia

Interventions

  • pregabalinDrug

  • placeboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the efficacy of pregabalin (BID) compared with placebo in assessing the durability of effect for the treatment of pain associated with fibromyalgia among patients who initially respond to open-label pregabalin using Pain Visual Analog Scale

Locations

109 sites in 1 country. Site status is shown where the registry gives one.

  • Pfizer Investigational Site

    Anniston, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Calera, Alabama

  • Pfizer Investigational Site

    Huntsville, Alabama

  • Pfizer Investigational Site

    Tuscaloosa, Alabama

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Scottsdale, Arizona

  • Pfizer Investigational Site

    Fayetteville, Arkansas

  • Pfizer Investigational Site

    Hot Springs, Arkansas

  • Pfizer Investigational Site

    Anaheim, California

  • Pfizer Investigational Site

    Carmichael, California

  • Pfizer Investigational Site

    Fresno, California

  • Pfizer Investigational Site

    Los Alamitos, California

  • Pfizer Investigational Site

    Northridge, California

  • Pfizer Investigational Site

    Pismo Beach, California

  • Pfizer Investigational Site

    Santa Ana, California

  • Pfizer Investigational Site

    Walnut Creek, California

  • Pfizer Investigational Site

    Whittier, California

  • Pfizer Investigational Site

    Denver, Colorado

  • Pfizer Investigational Site

    Stratford, Connecticut

  • Pfizer Investigational Site

    Newark, Delaware

  • Pfizer Investigational Site

    Washington D.C., District of Columbia

  • Pfizer Investigational Site

    Chiefland, Florida

  • Pfizer Investigational Site

    Clearwater, Florida

  • Pfizer Investigational Site

    Kissimmee, Florida

  • Pfizer Investigational Site

    Miami, Florida

  • Pfizer Investigational Site

    Ocala, Florida

  • Pfizer Investigational Site

    Ocala, Florida

  • Pfizer Investigational Site

    Palm Harbor, Florida

  • Pfizer Investigational Site

    Palm Springs, Florida

  • Pfizer Investigational Site

    Plantation, Florida

  • Pfizer Investigational Site

    Plantation, Florida

  • Pfizer Investigational Site

    St. Petersburg, Florida

  • Pfizer Investigational Site

    Sunrise, Florida

  • Pfizer Investigational Site

    Tampa, Florida

  • Pfizer Investigational Site

    West Palm Beach, Florida

  • Pfizer Investigational Site

    Atlanta, Georgia

  • Pfizer Investigational Site

    Gurnee, Illinois

  • Pfizer Investigational Site

    Peoria, Illinois

Showing 40 of 109 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.